• Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$212.70
+0.30 (1.20%)
Get New Aetna Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AET and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AET

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Aetna in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $212.70.

This chart shows the closing price for AET for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Aetna. This rating has held steady since October 2019, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/22/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/20/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/20/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/31/2018Credit Suisse GroupLower Price TargetNeutral ➝ Neutral$207.00 ➝ $205.00Low
10/31/2018CitigroupBoost Price TargetNeutral ➝ Neutral$202.00 ➝ $206.00Low
10/30/2018Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$212.00 ➝ $206.00Low
10/30/2018Cantor FitzgeraldReiterated RatingHold$204.00Low
10/22/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$202.00 ➝ $207.00Low
8/22/2018Cantor FitzgeraldDowngradeOverweight ➝ Neutral$202.00Low
8/2/2018Cantor FitzgeraldReiterated RatingBuy$202.00Low
5/14/2018Credit Suisse GroupLower Price TargetNeutral ➝ Neutral$208.00 ➝ $194.00Low
5/1/2018Cantor FitzgeraldUpgradeNeutral ➝ OverweightMedium
1/31/2018Jefferies Financial GroupReiterated RatingHold$205.00Low
1/31/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$200.00 ➝ $208.00Medium
1/31/2018CitigroupDowngradeBuy ➝ Neutral$187.89 ➝ $212.00Low
1/30/2018CowenReiterated RatingBuy$212.00Low
1/30/2018Piper Jaffray CompaniesReiterated RatingBuy$212.00Low
1/22/2018Deutsche Bank AktiengesellschaftUpgradeHold ➝ Buy$195.00 ➝ $212.00Low
1/3/2018Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$136.00Low
12/20/2017Morgan StanleyDowngradeOverweight ➝ Equal Weight$179.00Low
12/6/2017Credit Suisse GroupReiterated RatingNeutral$174.00 ➝ $195.00Low
12/6/2017ArgusDowngradeBuy ➝ Hold$185.00Low
12/4/2017Wells Fargo & CompanyReiterated RatingOutperform$200.00 ➝ $208.00High
11/3/2017Piper Jaffray CompaniesReiterated RatingHold$187.00N/A
11/3/2017Raymond JamesUpgradeMarket Perform ➝ Outperform$200.00N/A
11/2/2017Credit Suisse GroupInitiated CoverageNeutral$174.00N/A
11/2/2017CitigroupBoost Price TargetBuy$183.00 ➝ $197.00N/A
11/1/2017Jefferies Financial GroupBoost Price TargetHold$165.00 ➝ $185.00N/A
10/27/2017BMO Capital MarketsBoost Price TargetMarket Perform$175.00 ➝ $200.00N/A
10/26/2017Cantor FitzgeraldDowngradeOverweight ➝ NeutralN/A
10/23/2017Cantor FitzgeraldReiterated RatingOverweight ➝ Neutral$175.00N/A
10/16/2017BMO Capital MarketsInitiated CoverageMarket Perform$175.00N/A
10/13/2017Jefferies Financial GroupBoost Price TargetHold$163.00 ➝ $165.00N/A
9/12/2017ArgusReiterated RatingBuy$165.00 ➝ $185.00Low
8/17/2017Morgan StanleyBoost Price TargetOverweight$172.00 ➝ $179.00Low
8/9/2017Cantor FitzgeraldReiterated RatingOverweight$150.00 ➝ $175.00Low
8/7/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$157.00 ➝ $163.00Low
8/4/2017Jefferies Financial GroupReiterated RatingHold$157.00 ➝ $163.00Low
8/4/2017Royal Bank of CanadaBoost Price TargetOutperform ➝ Outperform$162.00 ➝ $171.00Medium
7/13/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$144.00 ➝ $157.00Low
7/13/2017Credit Suisse GroupReiterated RatingOutperform$160.00 ➝ $165.00Low
6/28/2017CitigroupInitiated CoverageBuy ➝ Buy$180.00Low
6/9/2017Royal Bank of CanadaBoost Price TargetOutperform$147.00 ➝ $162.00Low
6/6/2017Morgan StanleyInitiated CoverageOverweight ➝ Overweight$162.00Medium
5/30/2017ArgusReiterated RatingBuy$145.00 ➝ $165.00Low
5/27/2017CowenSet Price TargetBuy$145.00 ➝ $170.00N/A
5/17/2017Credit Suisse GroupReiterated RatingBuy$155.00Low
5/17/2017UBS GroupReiterated RatingBuy$147.00 ➝ $160.00N/A
5/17/2017Bank of AmericaReiterated RatingBuy$160.00 ➝ $168.00Medium
5/16/2017Stifel NicolausBoost Price TargetBuy ➝ Buy$150.00 ➝ $158.00Low
5/15/2017BarclaysReiterated RatingOverweight$162.00Low
5/12/2017Cantor FitzgeraldReiterated RatingBuy$150.00Low
5/11/2017Cleveland ResearchUpgradeNeutral ➝ BuyLow
5/3/2017Jefferies Financial GroupReiterated RatingHold$133.00 ➝ $140.00Low
5/3/2017Stifel NicolausReiterated RatingBuy$130.00 ➝ $150.00Low
5/3/2017Cantor FitzgeraldReiterated RatingOverweight$140.00 ➝ $150.00Low
4/24/2017Royal Bank of CanadaReiterated RatingBuy$145.00Low
4/13/2017Jefferies Financial GroupReiterated RatingHold$133.00Low
4/5/2017Deutsche Bank AktiengesellschaftInitiated CoverageHold$135.00Low
4/3/2017CIBCReiterated RatingOutperformLow
3/31/2017OppenheimerReiterated RatingOutperformLow
2/21/2017Cantor FitzgeraldReiterated RatingOverweight$140.00N/A
2/14/2017Cantor FitzgeraldReiterated RatingOverweightN/A
2/7/2017Cantor FitzgeraldInitiated CoverageOverweightN/A
2/6/2017Cantor FitzgeraldReiterated RatingBuy$140.00N/A
2/1/2017Jefferies Financial GroupBoost Price Target$133.00N/A
1/31/2017Sanford C. BernsteinDowngradeOutperform ➝ Market PerformN/A
1/24/2017SVB LeerinkDowngradeOutperform ➝ Market Perform$135.00N/A
1/4/2017Piper Jaffray CompaniesInitiated CoverageNeutral$136.00N/A
1/3/2017Royal Bank of CanadaReiterated RatingBuy$145.00N/A
12/28/2016ArgusReiterated RatingBuy$130.00 ➝ $145.00N/A
12/23/2016Cantor FitzgeraldReiterated RatingBuyN/A
12/16/2016Jefferies Financial GroupReiterated RatingHold$130.00N/A
11/14/2016Sanford C. BernsteinDowngradeOutperform ➝ Market Perform$132.00N/A
11/11/2016Credit Suisse GroupUpgradeNeutral ➝ Outperform$120.00 ➝ $125.00N/A
11/7/2016BarclaysReiterated RatingBuy$142.00N/A
(Data available from 10/20/2016 forward)

News Sentiment Rating

0.27 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/24/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/23/2021
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/23/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/22/2021
  • 2 very positive mentions
  • 3 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
7/22/2021
  • 4 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/21/2021
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/20/2021
  • 0 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/20/2021

Current Sentiment

  • 0 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Aetna logo
Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages various retirement products comprising pension and annuity products primarily for tax-qualified pension plans. The company provides its products and services to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. was founded in 1853 and is based in Hartford, Connecticut.
Read More

Today's Range

Now: $212.70
Low: $211.79
High: $213.36

50 Day Range

MA: $212.70
Low: $212.70
High: $212.70

52 Week Range

Now: $212.70
Low: $166.88
High: $213.36

Volume

11,862,705 shs

Average Volume

3,688,920 shs

Market Capitalization

$69.64 billion

P/E Ratio

21.57

Dividend Yield

0.94%

Beta

0.71

Frequently Asked Questions

What sell-side analysts currently cover shares of Aetna?

The following Wall Street sell-side analysts have issued research reports on Aetna in the last twelve months:
View the latest analyst ratings for AET.

What is the current price target for Aetna?

0 Wall Street analysts have set twelve-month price targets for Aetna in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Aetna in the next year.
View the latest price targets for AET.

What is the current consensus analyst rating for Aetna?

Aetna currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for AET.

What other companies compete with Aetna?

Other companies that are similar to Aetna include UnitedHealth Group, Anthem, Cigna, Humana, Centene, Molina Healthcare, Magellan Health and Triple-S Management.

How do I contact Aetna's investor relations team?

Aetna's physical mailing address is 151 FARMINGTON AVENUE, HARTFORD CT, 06156. The company's listed phone number is 860-273-0123 and its investor relations email address is [email protected] The official website for Aetna is www.aetna.com.